ros1 rearrangement Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

Massachusetts General Hospital (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadkinase inhibitor therapy

I am/have/hadcns lesion

I am/have/hadmajor surgery

I am/have/hadmalabsorption

I am/have/hadimmunohistochemistry

I am/have/haddiscomfort

I am/have/hadcore biopsy

I am/have/hadmetastasis

I am/have/hadtyrosine

I am/have/hadcore needle biopsy

I am/have/hadros1 rearrangement

I am/have/hadsmall cell lung cancer

I am/have/hadcancer

I am/have/hadleptomeningeal disease

I am/have/hadpleural effusion

I am/have/hadseizure

I am/have/hadmet amplification

I am/have/hadros1 gene rearrangement

I am/have/hadtubal ligation

I am/have/hadmale sterilization

added new label for I am/have/had

more

I am looking for

I am looking forcrizotinib

I am looking forprobe

I am looking foranti-epileptic

I am looking forantiepileptics

I am looking forbinimetinib

I am looking forlacosamide

I am looking forcombinations

I am looking fortyrosine

I am looking forvalproic acid

I am looking forkinase inhibitor

I am looking forlorlatinib

I am looking forlevetiracetam

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Lorlatinib Combinations in Lung Cancer

This research study is evaluating Lorlatinib in combination with Crizotinib or Binimetinib as a possible treatment for either anaplastic lymphoma kinase (ALK)-positive lung cancer or ROS1-positive lung cancer. This research study involves three study drugs. Lorlatinib Binimetinib Crizotinib

kinase inhibitor therapy

cns lesion

malabsorption

major surgery

probe

0 views
16 Feb, 2024
2 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.